Another Exposé About Drugmakers Co-opting Patient Advocates

by Admin | September 20, 2016 12:17 pm

September 20, 2016—Yesterday we wrote about how The New York Times and the Center for Public Integrity exposed how drug companies co-opt patient-advocacy and civic groups[1] with big donations. Some disease-awareness and civic groups, we noted, parrot negative pharmaceutical industry talking points about the 340B drug discount program[2]. You can add Bloomberg Markets to the list of news organizations investigating the cozy relationship between drugmakers and patient advocates.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[3].    Already registered? Click here to login[4]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2016/09/another-expose-about-drugmakers-co-opting-patient-advocates/

---